Tangerine or Red Tomato Juice in Treating Patients With Prostate Cancer Undergoing Surgery

NACompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

September 22, 2016

Study Completion Date

September 22, 2016

Conditions
Stage I Prostate CancerStage IIA Prostate CancerStage IIB Prostate CancerStage III Prostate CancerStage IV Prostate Cancer
Interventions
DIETARY_SUPPLEMENT

dietary intervention (tangerine tomato juice)

Group II will consume two 5.5 oz. cans of tangerine tomato juice every day until their scheduled surgery. (approximately 4 weeks).

DIETARY_SUPPLEMENT

dietary intervention (red tomato juice)

Group III will consume two 5.5 oz. cans of red tomato juice every day until their scheduled surgery (approximately 4 weeks).red tomato juice

OTHER

questionnaire administration

Men enrolled in the study will be asked to complete a 3-Day Food Record and a series of additional questionnaires (urologic symptom and quality of life questionnaire) at home.

OTHER

Correlative studies

Blood and urine samples at enrollment and blood, urine, and prostate tissue at the time of surgery to determine compliance with the intervention product and tomato phytochemical biodistribution. Additionally, we will correlate each type of tomato juice with lycopene presence in plasma, urine, and tissue provided by subjects on the day of surgery.

Trial Locations (2)

43016

OhioHealth Dublin Methodist Hospital, Dublin

43210

Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus

All Listed Sponsors
collaborator

Riverside Methodist Hospital

OTHER

lead

Ohio State University Comprehensive Cancer Center

OTHER

NCT02144649 - Tangerine or Red Tomato Juice in Treating Patients With Prostate Cancer Undergoing Surgery | Biotech Hunter | Biotech Hunter